Cerecor Inc. is a Baltimore-based biopharmaceutical company developing innovative treatments to make a difference in the lives of patients suffering from neuropsychiatric diseases by addressing the unmet medical needs of underserved patient segments. We are committed to the development of drugs that improve lives by applying our extensive knowledge and experience in central nervous system disorders.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 07/21/14 | $16,250,000 | Series B |
Apple Tree Partners MPM Capital | undisclosed |
